Adrenomyeloneuropathy

  • Sep 26, 2018 endpts.com
    Fattaey out, Dentzer up at Curis; Belgian investors back Spanish orphan drug biotech; Verastem scores China deal – Endpoints News
    Read More
  • Sep 26, 2018 www.fiercebiotech.com
    Roche-backed Minoryx raises €21M to expand CNS R&D – FierceBiotech
    Read More
  • Sep 25, 2018 globenewswire.com
    Nutra Pharma announces updates with EuroAmerican IP & BioArmor, LLC, a Service-Disabled Veteran-Owned Small Business for Sales through GoVets.com – GlobeNewswire
    Read More
  • Jul 17, 2018 www.prnewswire.com
    SOM Biotech Announces Initiation of Phase 2a Clinical Trial of SOM3355 in Huntington’s Disease Patients – PR Newswire
    Read More
  • Jul 03, 2018 globenewswire.com
    Nutra Pharma Announces Direct Mail Campaign for Pet Pain-Away™ Private Label Brand – GlobeNewswire
    Read More
  • Jun 28, 2018 globenewswire.com
    Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing – GlobeNewswire
    Read More
  • Jun 05, 2018 www.businesswire.com
    Pipeline Review for Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) – H1 2018 – ResearchAndMarkets.com – Business Wire
    Read More
  • Apr 19, 2018 globenewswire.com
    Nutra Pharma Partners with NxGen Brands for Nyloxin® Distribution – GlobeNewswire
    Read More
  • Apr 10, 2018 globenewswire.com
    Nutra Pharma Files Provisional Patent for the Treatment of Amyotrophic Lateral Sclerosis (ALS) – GlobeNewswire
    Read More

Connect. Empower. Inspire.